DNA immunization targeting the skin: Molecular control of adaptive immunity

Journal of Investigative Dermatology

Volumn 111, Issue 2, 1998, Pages 183-188

  Tüting, Thomas ^a,b   Storkus, Walter J ^b   Falo Jr , Louis D ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; Gene gun; Langerhans cells; Nucleic acid vaccine

Indexed keywords

ALPHA INTERFERON; B7 ANTIGEN; CYTOKINE; DNA VACCINE; INTERLEUKIN 12; INTERLEUKIN 2; PLASMID DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN PRESENTING CELL; BIOLISTIC TRANSFORMATION; CANCER CONTROL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG TARGETING; GENE TRANSFER; GENETIC ENGINEERING; IMMUNOMODULATION; INFECTION; LANGERHANS CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKIN CARCINOMA; VACCINE PRODUCTION;

EID: 0031926854     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1998.00261.x     Document Type: Review

References (72)

1. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 157:1840-1845, 1996
2. Belardelli F, Gresser I: The neglected role of type I interferon in T-cell response: implications for its clinical use. Immunol Today 17:369-372, 1996
3. Boon T, Van der Bruggen P: Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725-729, 1996
4. Boyer JD, Wang B, Ugen KE, et al: In vivo protective anti-HIV immune responses in non-human primates through DNA immunization. J Med Primatol 25:242-250, 1996
5. Boyer JD, Ugen KE, Wang B, et al: Protection of chimpanzees from high-dose heterologous HIV-1 challenge by DNA vaccination. Nature Med 3:526-532, 1997
6. Carson DA, Raz E: Oligonucleotide adjuvants for T helper 1 (Th1) -specific vaccination. J Exp Med 186:1621-1622, 1997
7. Casares S, Inaba K, Brumeanu T-D, Steinman RM, Bona CA: Antigen presentation by dendritic cells after immuniation with DNA encoding a major histocomapatibility complex class II-restricted viral epitope. J Exp Med 186:1481-1486, 1997
8. Cella M, Sallusto F, Lanzavecchia A: Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10-16, 1997
9. Chambers CA, Allison JP: Co-stimulation in T cell responses. Curr Opin Immunol 9:396-404, 1997
10. Chow YH, Huang WL, Chi WK, Chu YD, Tao MH: Improvement of hepatitis B virus DNA vaccines by plasmids coexpressing hepatitis B surface antigen and interleukin-2. J Virol 71:169-178, 1997
11. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CgG oligonucleotides act as adjuvants that switch on T helper 1 (Th1) Immunity. J Exp Med 186:1623-1631, 1997
12. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr: DNA-based immunization by in vivo transrection of dendritic cells. Nature Med 2:1122-1128, 1996
13. Conry RM, Widera G, LoBuglio AF, et al: Selected strategies to augment polynucleotide immunization. Gene Ther 3:67-74, 1996
14. Corr M, Lee DJ, Carson DA, Tighe H: Gene vaccination with naked plasmid DNA. Mechanism of CTI priming. J Exp Med 184:1555-1560, 1996
15. Corr M, Tighe H, Lee D, Dudler J, Trieu M, Brinson DC, Carson DA: Costimulation provided by DNA Immunization enhances antitumor immunity. J Immunol 159:4999-5004, 1997
16. Cresswell P: Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259, 1994
17. Davis HL, Michel ML, Whalen RG: DNA-based immunization iduces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Molec Genet 2:1847-1851, 1993
18. Davis HL, McCluskie MJ, Gerin JL, Purcell RH: DNA vaccine for hepatitis B. Evidence for immunogenicity in chimpanzees and comparison with other vaccines. Proc Natl Acad Sci USA 93:7213-7218, 1996
19. Doe B, Selby M, Barnett S, Baenziger J, Walker CM: Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells. Proc Natl Acad Sci USA 93:8578-8583, 1996
20. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA vaccines. Ann Rev Immunol 15:617-648, 1997
21. Feltquate DM, Heaney S, Webster RG, Robinson HL: Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 158:2278-2284, 1997
22. Fu T-M, Ulmer JB, Caulfield MJ, et al: Priming of cytotoxic T lymphocytes by DNA vaccines: Requirements for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol Med 3:362-371, 1997
23. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 90:11478-11482, 1993
24. Geissler M, Gesien A, Tokushige K, Wands JR: Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 158:1231-1237, 1997
25. Grewal IS, Flavell RA: The role of CD40 ligand in costimulation and T-cell activation. Immunol Rev 153:85-106, 1996
26. Hsu C-H, Chua K-Y, Tao M-H, Lai Y-I, Wu H-D, Huang S-K, Hsieh K-H: Immunoprophylaxis of allergen-induced immunoglogulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nature Med 2:540-544, 1996
27. Irvine KR, Rao RB, Rosenberg SA, Restifo NP: Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases. J Immunol 156:238-245, 1996
28. Iwasaki A, Stiernholm BJN, Chan AK, Berinstein NI, Barber BH: Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines. J Immunol 158:4591-4601, 1997a
29. Iwasaki A, Torres CAT, Ohashi PS, Robbinson HL, Barber BH: The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites. J Immunol 159:11-14, 1997b
30. Kim JJ, Ayyavoo V, Bagarazzi MI, et al: In vivo engineering of a cellular immune response by coadministration of 11-12 expression vector with a DNA immunogen. J Immunol 158:816-826, 1997a
31. Kim JJ, Bagarazzi ML, Trivedi N, et al: Engineering of in vivo immune responses to DNA immunization via co-delivery of costimulatory molecule genes. Nature Biotechnol 15:641-646, 1997b
32. Kitajima T, Caceres-Dittmar G, Tapia FJ, Jester J, Bergstresser PR, Takashima A: T cell-mediated terminal maturation of dendritic cells: loss of adhesive and phagocytic capacities. J Immunol 157:2340-2347, 1996
33. Klein TM, Wolf ED, Wu R, Sanford JC: High-velocity microprojectiles for delivering nucleic acids into living cells. Nature (London) 327:70-73, 1987
34. Klinman DM, Yi A-K, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacterial DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon γ. Proc Natl Acad Sci USA 93:2879-2883, 1996
35. Klinman DM, Yanishchikov G, Ishigatsubo Y: Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 158:3635-3639, 1997
36. Klinman DM, Sechler JMG, Conover J, Gu M, Rosenberg AS: Contribution of cells at the site of DNA vaccination to the generation of antigen-specific immunity and memory. J Immunol 160:2388-2392, 1998
37. Koch F, Stanzl U, Jennewein P, et al: High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL- 10. J Exp Med 184:741-746, 1996
38. Lanzavecchia A: Understanding the mechanisms of sustained signaling and T cell activation. J Exp Med 185:1717-1719, 1997
39. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233-258, 1996
40. Lu L, Quian S, Hershberger PA, Rudert WA, Lynch DH, Thomson AW: Fas Ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation. J Immunol 158:5676-5684, 1997
41. Luger TA, Bhardwaj RS, Grabbe S, Schwarz T: Regulation of the immune response by epidermal cytokines and neurohormones. J Dermatol Sci 13:5-10, 1996
42. Macatonia SE, Edwards AJ, Knight SC: Dendritic cells and the initiation of contact sensitivity to fluorescein isothiocyanate. Immunology 59:509-514, 1986
43. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P: Localization of antigen on lymph node cells after exposure to contact sensitizer fluorescein isothiocyanate: functional and morphological studies. J Exp Med 166:1654-1667, 1987
44. Manickan E, Kanangat S, Rouse RJD, Yu Z, Rouse BT: Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukocyte Biol 61:125-132, 1997
45. McKinney EC, Streilein JW: On the extraordinary capacity of allogeneic I angerhans cells to prime cytotoxic T-cells in vivo. J Immunol 143:1560-1564, 1989
46. Mendoza RB, Cantwell MJ, Kipps TJ: Cutting edge: Immunostimulatory effects of a plasmid expressing CD40 ligand (CD154) on gene immunization. J Immunol 159:5777-5781, 1997
47. Pardoll DM, Beckerleg AM: Exposing the immunology of naked DNA. Immunity 3:165-169, 1995
48. Pertmer TM, Roberts TR, Haynes JR: Influenza virus nucleoprotein-specific immunoglubulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 76:6119-6125, 1996
49. Raz E, Tighe H, Sato Y, et al: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 91:9519-9523, 1996
50. Robinson HL, Hunt LA, Webster RC: Protection against a lethal influenza virus challenge by immunization with a hemagglutinin-expressing plasmid DNA. Vaccine 11:957-960, 1993
51. Roman M, Martin-Orozco E, Goodman JS, et al: Immunostimulalory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 3:849-854, 1997
52. Rosato A, Zambon A, Milan G, et al: CTL response and protection against P815 tumor challenge in mice immunized with DNA expressing the tumor-specific antigen P185. Hum Gene Ther 8:1451-1458, 1997
53. Sato Y, Roman M, Tighe H, et al: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 273:352-354, 1996
54. Stacey KJ, Sweet MJ, Hume DA: Macrophages ingest and are activated by bacterial DNA. J Immunol 157:2116-2122, 1996
55. Steinman RM: The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 9:271-296, 1991
56. Syrengelas AD, Chen TT, Levy R: DNA immunization induces protective immunity against B-cell lymphoma. Nature Med 2:1038-1041, 1996
57. Tang DC, DeVit MJ, Johnston SA: Genetic immunization: a simple method for eliciting an immune response. Nature (London) 356:152-154, 1992
58. Timares-Lebow L. Takashima A, Johnston SA: Enhanced immune responses by inoculation of a transfected dendritic cell line (XS106). J Invest Derm 109:266, 1997
59. Torres CAT, Iwasaki A, Barber BH, Robinson HL: Differnetial dependence on target site tissue for gene gun and intramuscular DNA immunizations. J Immunol (Cutting Edge) 158:4529-4532, 1997
60. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13:251-276, 1995
61. Tsuji T, Hamajima K, Fukushima J, et al: Enhancement of cell-mediated immunity against HIV-1 induced by coinoculation of plasmid-encoded HIV-1 antigen with plasmid expressing IL-12. J Immunol 158:4008-4013, 1997
62. Tüting T, DeLeo A, Lotze MT, Storkus WJ: Bone marrow-derived dendritic cells genetically-modified to express tumor-associated antigens induce antitumor immunity in vivo. Eur J Immunol 27:2702-2707, 1997
63. Tüting T, Wilson CC, Martin DM, et al: Autolgous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T-cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-alpha. J. Immunol 160:1139-1147, 1998
64. Ulmer JB, Donnnelly JJ, Parker SE, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745-1749, 1993
65. Ulmer JB, Deck RR, Dewitt CM, Donnely JJ, Liu MA: Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells. Immunol 89:59-67, 1996
66. Waisman A, Ruiz PJ, Hirschberg DL, et al: Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyolitis and activates Th2 immunity. Nature Med 2:899-905, 1996
67. Wang B, Ugen KE, Srikantan V, et al: Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 90:4156-4160, 1993
68. Watts C: Capture and processing of exogenous antigens for presentation on MHC molecules. Annu Rev Immunol 15:821, 1997
69. Williams RS, Johnston SA, Reidy M, DeVit MJ, McElligott SC, Sanford JC: Introduction of foreign genes into tissues of living mice by DNA-coated microprojectiles. Proc Natl Acad Sci USA 88:2726-2730, 1991
70. Xiang Z, Ertl HCJ: Manipulation of the immine response to a plasimd-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 2:129-135, 1995
71. Yang N-S, Burkholder J, Roberts B, Martinell B, McCabe D: In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc. Natl Acad Sci USA 87:9568-9572, 1990
72. York IA, Rock KL: Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 14:369-396, 1996